back to cluster viewer
cluster path 11101000011101110
74 words, 7,427 tokens
freq alpha suffix
Words in frequency order
1 | approved | 4,770
|
2 | licensed | 1,042
|
3 | marketed | 726
|
4 | fda-approved | 187
|
5 | authorized | 131
|
6 | accredited | 114
|
7 | banned | 110
|
8 | commercialized | 67
|
9 | reformulated | 49
|
10 | authorised | 40
|
11 | legislated | 20
|
12 | licenced | 17
|
13 | sanctioned | 17
|
14 | repurposed | 13
|
15 | fielded | 12
|
16 | praised | 9
|
17 | utilizable | 8
|
18 | budgeted | 6
|
19 | alexidine | 5
|
20 | antinicotinic | 4
|
21 | commercialised | 4
|
22 | multicomponents | 4
|
23 | nonefficacious | 4
|
24 | a₃r | 3
|
25 | indivisible | 3
|
26 | onshore | 3
|
27 | turgidity | 3
|
28 | 54gy | 2
|
29 | coveted | 2
|
30 | cxcr3-independent | 2
|
31 | desulfinated | 2
|
32 | fda-indicated | 2
|
33 | fda-licensed | 2
|
34 | frontrunner | 2
|
35 | post-launch | 2
|
36 | €227 | 2
|
37 | -centric | 1
|
38 | 0.59/0.42 | 1
|
39 | 20-µg | 1
|
40 | 4.2.8. | 1
|
41 | 50/07 | 1
|
42 | administration-labeled | 1
|
43 | aggrevated | 1
|
44 | aromatasis | 1
|
45 | bq-123/the | 1
|
46 | cgs35066 | 1
|
47 | creatinine-serum | 1
|
48 | deemphasized | 1
|
49 | drawn-up | 1
|
50 | evoked-activity | 1
|
51 | firing.this | 1
|
52 | geraldine | 1
|
53 | implicated-after | 1
|
54 | increaseded | 1
|
55 | investigatable | 1
|
56 | kw-3902 | 1
|
57 | l371,257 | 1
|
58 | larynx-preserving | 1
|
59 | ly2109761 | 1
|
60 | mclr-only | 1
|
61 | medallion | 1
|
62 | non-hc | 1
|
63 | nonpestiferous | 1
|
64 | park/dodson | 1
|
65 | performed-one | 1
|
66 | pf-3845 | 1
|
67 | piqued | 1
|
68 | protocol.total | 1
|
69 | reapproved | 1
|
70 | smuggled | 1
|
71 | stoma-free | 1
|
72 | trial-will | 1
|
73 | us-fda-approved | 1
|
74 | ω-agatoxin | 1
|
Words in alphabetical order
1 | -centric | 1
|
2 | 0.59/0.42 | 1
|
3 | 20-µg | 1
|
4 | 4.2.8. | 1
|
5 | 50/07 | 1
|
6 | 54gy | 2
|
7 | accredited | 114
|
8 | administration-labeled | 1
|
9 | aggrevated | 1
|
10 | alexidine | 5
|
11 | antinicotinic | 4
|
12 | approved | 4,770
|
13 | aromatasis | 1
|
14 | authorised | 40
|
15 | authorized | 131
|
16 | a₃r | 3
|
17 | banned | 110
|
18 | bq-123/the | 1
|
19 | budgeted | 6
|
20 | cgs35066 | 1
|
21 | commercialised | 4
|
22 | commercialized | 67
|
23 | coveted | 2
|
24 | creatinine-serum | 1
|
25 | cxcr3-independent | 2
|
26 | deemphasized | 1
|
27 | desulfinated | 2
|
28 | drawn-up | 1
|
29 | evoked-activity | 1
|
30 | fda-approved | 187
|
31 | fda-indicated | 2
|
32 | fda-licensed | 2
|
33 | fielded | 12
|
34 | firing.this | 1
|
35 | frontrunner | 2
|
36 | geraldine | 1
|
37 | implicated-after | 1
|
38 | increaseded | 1
|
39 | indivisible | 3
|
40 | investigatable | 1
|
41 | kw-3902 | 1
|
42 | l371,257 | 1
|
43 | larynx-preserving | 1
|
44 | legislated | 20
|
45 | licenced | 17
|
46 | licensed | 1,042
|
47 | ly2109761 | 1
|
48 | marketed | 726
|
49 | mclr-only | 1
|
50 | medallion | 1
|
51 | multicomponents | 4
|
52 | non-hc | 1
|
53 | nonefficacious | 4
|
54 | nonpestiferous | 1
|
55 | onshore | 3
|
56 | park/dodson | 1
|
57 | performed-one | 1
|
58 | pf-3845 | 1
|
59 | piqued | 1
|
60 | post-launch | 2
|
61 | praised | 9
|
62 | protocol.total | 1
|
63 | reapproved | 1
|
64 | reformulated | 49
|
65 | repurposed | 13
|
66 | sanctioned | 17
|
67 | smuggled | 1
|
68 | stoma-free | 1
|
69 | trial-will | 1
|
70 | turgidity | 3
|
71 | us-fda-approved | 1
|
72 | utilizable | 8
|
73 | ω-agatoxin | 1
|
74 | €227 | 2
|
Words in suffix order
1 | 4.2.8. | 1
|
2 | ly2109761 | 1
|
3 | kw-3902 | 1
|
4 | 0.59/0.42 | 1
|
5 | pf-3845 | 1
|
6 | cgs35066 | 1
|
7 | 50/07 | 1
|
8 | €227 | 2
|
9 | l371,257 | 1
|
10 | non-hc | 1
|
11 | antinicotinic | 4
|
12 | -centric | 1
|
13 | licenced | 17
|
14 | increaseded | 1
|
15 | fielded | 12
|
16 | administration-labeled | 1
|
17 | smuggled | 1
|
18 | banned | 110
|
19 | sanctioned | 17
|
20 | praised | 9
|
21 | commercialised | 4
|
22 | authorised | 40
|
23 | licensed | 1,042
|
24 | fda-licensed | 2
|
25 | repurposed | 13
|
26 | fda-indicated | 2
|
27 | legislated | 20
|
28 | reformulated | 49
|
29 | desulfinated | 2
|
30 | aggrevated | 1
|
31 | budgeted | 6
|
32 | marketed | 726
|
33 | coveted | 2
|
34 | accredited | 114
|
35 | piqued | 1
|
36 | approved | 4,770
|
37 | fda-approved | 187
|
38 | us-fda-approved | 1
|
39 | reapproved | 1
|
40 | commercialized | 67
|
41 | authorized | 131
|
42 | deemphasized | 1
|
43 | stoma-free | 1
|
44 | bq-123/the | 1
|
45 | investigatable | 1
|
46 | utilizable | 8
|
47 | indivisible | 3
|
48 | alexidine | 5
|
49 | geraldine | 1
|
50 | performed-one | 1
|
51 | onshore | 3
|
52 | larynx-preserving | 1
|
53 | 20-µg | 1
|
54 | post-launch | 2
|
55 | protocol.total | 1
|
56 | trial-will | 1
|
57 | creatinine-serum | 1
|
58 | ω-agatoxin | 1
|
59 | medallion | 1
|
60 | park/dodson | 1
|
61 | drawn-up | 1
|
62 | frontrunner | 2
|
63 | implicated-after | 1
|
64 | a₃r | 3
|
65 | firing.this | 1
|
66 | aromatasis | 1
|
67 | multicomponents | 4
|
68 | nonefficacious | 4
|
69 | nonpestiferous | 1
|
70 | cxcr3-independent | 2
|
71 | 54gy | 2
|
72 | mclr-only | 1
|
73 | turgidity | 3
|
74 | evoked-activity | 1
|